drug injecting
Recently Published Documents


TOTAL DOCUMENTS

73
(FIVE YEARS 10)

H-INDEX

19
(FIVE YEARS 1)

2021 ◽  
Vol 18 (1) ◽  
Author(s):  
Juan-Miguel Guerras ◽  
Patricia García de Olalla ◽  
María José Belza ◽  
Luis de la Fuente ◽  
David Palma ◽  
...  

Abstract Background We estimate the prevalence of drug injection, the variables associated with having ever injected and the proportion of ever injectors whose first drug injection was for having sex; we describe the first drug injection episode, analyze the drugs most frequently injected and estimate the prevalence of risky injecting behaviors. Methods The participants were 3387 MSM without a previous HIV diagnosis attending four HIV/STI diagnosis services in Madrid and Barcelona. Lifetime prevalence and prevalence ratios (PRs) by different factors were calculated using Poisson regression models with robust variance. We compared the characteristics of first drug injection episode, lifetime injection and risky injecting behaviors of those whose first injection was for sex (FIS) with those whose was not (non-FIS). Results Lifetime prevalence of injection was 2.1% (CI 1.7–2.7). In the multivariate analysis, it was strongly associated with having been penetrated by more than five men in the last 12 months (aPR = 10.4; CI 2.5–43.4) and having met most of their partners at private parties (aPR = 7.5; CI 4.5–12.3), and less strongly with other factors. Of those who had ever injected drugs, 81.9% injected for sex the first time they injected drugs (FIS). At first injection, FIS participants had a mean age of 31 years, 62.7% used mephedrone and 32.2% methamphetamine on that occasion. Of this FIS group 39.0% had ever shared drugs or equipment and 82.6% had always shared for sex. Some 30.8% of non-FIS reported having also injected drugs for sex later on. Conclusions Only two out of a hundred had ever injected, most to have sex and with frequent drug or injecting equipment sharing. Injecting for sex is the most common first episode of drug injection and is the most efficient risky behavior for the transmission of HIV, hepatitis B or C and other blood-borne infections. MSM participating in private parties should be considered a priority group for prevention policies.


2021 ◽  
Vol 90 ◽  
pp. 103056
Author(s):  
Meyers SA ◽  
Rafful C ◽  
Mittal ML ◽  
Smith LR ◽  
Tirado-Muñoz J ◽  
...  

2021 ◽  
Author(s):  
Judith Ann Levy ◽  
Mary Ellen Mackesy-Amiti ◽  
Mahbat Bakhromov ◽  
jonbek jonbekov ◽  
carl latkin

We developed and pilot-tested the Migrants’ Approached Self-Learning Intervention in HIV/AIDS for Tajiks (MASLIHAT). We recruited 30 Tajik labor migrants who inject drug in Moscow as peer educators (PEs) to attend the 5-session intervention, then share what they learned with their peers. Each PE recruited two drug-injecting network members for interviewing about their drug and sexual behavior at baseline, 6 weeks, 3 months, and 6 months post-intervention. GEE and mixed effects regression tested time and participant type effects on each outcome. HIV knowledge and risk perception increased among both PEs and network peers, while use of shared syringes, condomless sex, sex with a sex worker, and alcohol use decreased significantly for both groups at 6 weeks and 3 months with a sustained effect through 6 months. The MASLIHAT intervention proved successful in disseminating HIV prevention information and reducing HIV risk behavior over 6 months among both PEs and network members.


2020 ◽  
Vol 20 (1) ◽  
Author(s):  
Kostyantyn Dumchev ◽  
Marina Kornilova ◽  
Roksolana Kulchynska ◽  
Marianna Azarskova ◽  
Charles Vitek

2020 ◽  
Author(s):  
Brittnie E. Bloom ◽  
Sonia Jain ◽  
Xiaoying Sun ◽  
Richard S. Garfein ◽  
Steffanie A. Strathdee ◽  
...  

PLoS ONE ◽  
2019 ◽  
Vol 14 (5) ◽  
pp. e0217811 ◽  
Author(s):  
Meghan D. Morris ◽  
Erin Andrew ◽  
Judy Y. Tan ◽  
Lisa Maher ◽  
Colleen Hoff ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document